European Commission approves Bavarian Nordic monkeypox vaccine

 

Denmark bio pharmacy company Bavarian Nordic announced on the 25th that the European Commission of the European Union (EU) has approved the sale of its smallpox vaccine "Invanex" as a monkeypox vaccine. did. The European Medicines Agency (EMA) made a recommendation last week.


It is also the only approved monkeypox vaccine in the United States and Canada.


This approval is valid in all EU member states, as well as Iceland, Liechtenstein, and Norway.


Inquiries about the monkeypox vaccine are strong, and the company's stock price has risen 122% in the past three months.


Inquiries about the monkeypox vaccine are strong, and the company's stock price has risen 122% in the past three months.



Post a Comment

0 Comments